When Uncle Sam Comes Knocking: The 25-Year Handshake That Lasts Five Minutes

Picture this: A delegation arrives at your door with a briefcase full of promises and a 72-hour countdown clock. They're offering to help with your most pressing health crises—HIV, TB, malaria, the works. But here's the catch: you have three days to negotiate a deal that commits you to sharing your most sensitive health data for the next quarter-century, while they commit to funding you for just five years. Oh, and you're sitting at the table alone, without your neighbors, without your regional partners, just you and the world's most powerful country.

Welcome to the new era of US global health diplomacy, where the "America First Global Health Strategy" is touring African capitals with the speed of a pop-up sale and the stakes of a poker tournament where you didn't realize you'd wagered your house.

Since November 2025, roving US teams have been crisscrossing sub-Saharan Africa faster than you can say "memorandum of understanding," aiming to lock in bilateral health agreements with at least 16 African nations by December 31st. The pitch sounds reasonable enough at first blush: let's move beyond the inefficiencies of NGO-mediated aid, promote local ownership, create jobs, and build sustainable health systems. After all, nobody particularly enjoys being perpetually positioned as the recipient in an aid relationship that's older than most of the people working in it.

But here's where things get interesting—in that "may you live in interesting times" kind of way.

The Devil Wears Business Casual

The architecture of these proposed agreements reveals a fascinating asymmetry. African governments are being asked to commit to 25-year arrangements for sharing pathogens with epidemic potential—including physical specimens and genetic sequences—within five days of detection. In exchange, they receive five-year funding commitments, often reduced from previous levels. It's rather like being asked to sign a mortgage while your lender commits to a short-term lease. The math, as they say, is not mathing.

Consider Zambia: facing a $50 million cut in antiretroviral funding (attributed to past theft), yet expected to employ 1,723 field epidemiologists by 2026 at government expense. The agreement grants the US "at-will" access to digital health systems, including electronic medical records with personal data, ostensibly to monitor compliance with rules like prohibiting US funds for abortion services. One might wonder whether this is health diplomacy or the world's most elaborate IT audit.

The pathogen-sharing provisions are particularly intriguing. Within 25 years, quite a lot can happen—pandemics can emerge and recede, governments can change hands multiple times, and entire technologies can be invented, perfected, and obsoleted. Yet African countries are being asked to provide rapid access to potentially world-changing biological data with no guaranteed reciprocal benefits. No assured vaccines, no guaranteed therapeutics developed from shared pathogens, no binding commitments that the innovations born from African disease surveillance will return to African shores at affordable prices.

It's the epidemiological equivalent of providing the recipe for your grandmother's secret sauce and then being told you'll have to buy it back at market rates if you want to serve it at your own restaurant.

The Collective Bargaining Power We Left Behind

Here's what makes this particularly thorny: African countries are negotiating individually, country by country, rather than as a bloc. Anyone who's ever tried to negotiate a salary knows that information asymmetry and isolation work decisively in favor of the party with more leverage. The shift from multilateral frameworks—where countries could coordinate positions, share intelligence, and negotiate as a coalition—to bilateral agreements tilts the playing field rather dramatically.

Michel Kazatchkine of the Independent Panel for Pandemic Preparedness warns that bypassing the WHO's Pathogen Access and Benefit-Sharing (PABS) system could fragment global responses, giving US institutions preferential access while undermining the very equity principles that pandemic preparedness supposedly requires. It's a bit like deciding that instead of having international traffic laws, each country should negotiate separately with other countries about which side of the road to drive on. Efficient? Perhaps not.

The multilateral system, for all its bureaucratic baroque, offered something valuable: the ability to hold powerful actors accountable through collective voice. When you're one of 54 African nations speaking together, you have rather more moral and political weight than when you're Uganda having a quiet chat with Brad Smith (yes, the former Department of Government Efficiency leader now overseeing PEPFAR reorganization—because what says "health diplomacy" like efficiency consulting?).

But Wait, There's More! (Actual Opportunities Edition)

Now, before this reads like an uninterrupted dirge, let's acknowledge the potential silver linings, because they do exist and ignoring them would be intellectually dishonest.

First, the strategy does commit to continued funding for frontline commodities and health workers in the near term—HIV, TB, and malaria programs that have saved over 26 million lives aren't disappearing overnight. The US isn't pulling up stakes entirely; they're renegotiating the terms of engagement.

Second, initiatives like the $150 million Zipline drone delivery deal spanning Côte d'Ivoire, Ghana, Kenya, Nigeria, and Rwanda demonstrate genuine potential for infrastructure development and job creation. Drone networks that can deliver blood supplies and vaccines to remote areas? That's not colonialism; that's genuinely useful technology transfer.

Third, and perhaps most importantly, if African nations approach these negotiations strategically—and that's a significant "if"—there's room to transform these agreements from extractive arrangements into genuine partnerships. Chatham House analysis suggests opportunities for using US surveillance investments to strengthen primary healthcare, integrating laboratory networks, and building digital health infrastructure that serves national priorities beyond disease reporting. Bilateral agreements could include sunset clauses for US procurement mandates, transitioning to local products as manufacturing capacity grows, and buy-back provisions that guarantee markets for African-produced health commodities.

The key phrase here is "if negotiated well." Which brings us to the rather pressing question: how does one negotiate well when the negotiations are happening at breakneck speed, often with 24 to 72-hour country visits, and target completion by December 31st?

The Strategic Imperative

This is where African governments, civil society organizations, and health advocates need to move from reactive to proactive mode—and fast. The agreements aren't legally binding, which paradoxically offers both vulnerability and flexibility. Countries need to be involving diverse stakeholders: civil society, health workers, researchers, and affected communities shouldn't be finding out about these agreements after they're signed.

Metrics matter enormously. When agreements include targets like "HIV testing positives" without carefully defined denominators, you risk creating perverse incentives—reduced testing to lower absolute numbers, or inflated reporting through better surveillance that looks like failure. African negotiators need to refine these metrics ruthlessly, ensuring they measure actual health outcomes rather than creating bureaucratic traps.

Data sovereignty provisions need teeth. If sharing pathogen data is essential for global health security—and it is—then reciprocal benefit-sharing must be explicit, binding, and enforceable. This means guaranteed access to vaccines and therapeutics at affordable prices, technology transfer agreements, and capacity-building commitments that go beyond vague promises of future cooperation.

And perhaps most critically, African countries need to be talking to each other. The Africa CDC, the African Union, and regional economic communities should be coordinating positions, sharing information about what terms different countries are being offered, and developing common minimum standards that no member state falls below. The Americans may prefer bilateral negotiations, but nothing stops African countries from coordinating their bilateral positions multilaterally.

The Bottom Line

The "America First Global Health Strategy" is neither the apocalypse its harshest critics suggest nor the transformative partnership its architects claim. It's a negotiation—one where the power dynamics are unquestionably asymmetric, but also one where African agency, strategic thinking, and collective action can still shape outcomes significantly.

The question isn't whether these bilateral agreements will happen—they're happening right now, with implementation starting April 2026. The question is whether they will reinforce patterns of dependency and extraction, or whether they can be leveraged toward genuine partnership and African self-reliance.

Twenty-five years is a long time to commit to anything. Five years is barely enough time to see whether a health program works. The gap between these timelines tells you everything you need to know about who's taking the long view and who's managing quarterly returns.

The Call

To African health ministers, negotiators, and government officials: Slow down. Consult widely. Coordinate regionally. Don't let arbitrary deadlines force you into agreements that serve others' interests better than your own. Your citizens' health data is valuable—treat it accordingly.

To civil society, researchers, and health advocates: Don't wait for governments to invite you to the table. Organize, analyze these agreements as they emerge, and create public accountability mechanisms that track implementation and outcomes.

To international partners who believe in genuine health equity: Support African countries in these negotiations. Provide technical assistance, legal expertise, and comparative analysis. Multilateralism isn't dead unless we let it die through a thousand bilateral cuts.

And to all of us watching this unfold: Remember that global health security is genuinely global. Pathogens don't respect bilateral agreements, and neither should pandemic preparedness. The next health crisis won't wait for us to sort out who owns which data and who benefits from which innovation.

We can build systems that protect everyone, or we can build systems that protect some people while exploiting others' vulnerability. The 72-hour negotiation clock is ticking, but the consequences will outlast us all.

What's your take? Have you seen these negotiations happening in your country? Are we witnessing a necessary evolution in health diplomacy or a concerning retreat from global solidarity? The comments are yours—and unlike certain data-sharing agreements, there's no 25-year commitment required.

About the Author

Dr. Julius Kirimi Sindi is a global expert in research funding, policy impact, and donor relations. With extensive experience in analyzing philanthropy, business, and science funding, Dr. Sindi fosters sustainable and inclusive research ecosystems. He has facilitated international business relationships across Africa, Europe, and Asia. His upcoming book, "The Blueprint of Life Well Lived," explores successful strategies for navigating complex business environments while achieving sustainable growth. He is the author of an upcoming book How Societies Change and Why Most Reforms Fail, which introduces an African Theory of Scaling rooted in emotional truth, political safety, and system coherence. He is also the creator of The Daily Pulse, a widely read LinkedIn newsletter offering sharp, human-centered analysis of policy, politics, and development.